GW 5074

CAS No. 220904-83-6

GW 5074( GW-5074 | GW5074 )

Catalog No. M13521 CAS No. 220904-83-6

A potent, selective c-Raf inhibitor with IC50 of 9 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 32 In Stock
5MG 49 In Stock
10MG 81 In Stock
25MG 122 In Stock
50MG 154 In Stock
100MG 186 In Stock
200MG 267 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GW 5074
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective c-Raf inhibitor with IC50 of 9 nM.
  • Description
    A potent, selective c-Raf inhibitor with IC50 of 9 nM; shows >1000-fold selectivity for raf kinase versus CDK1, CDK2, c-src, ERK2, MEK, p38, Tie2, VEGFR2, and c-Fms.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    GW-5074 | GW5074
  • Pathway
    MAPK/ERK Signaling
  • Target
    Raf
  • Recptor
    C-Raf
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    220904-83-6
  • Formula Weight
    520.942
  • Molecular Formula
    C15H8Br2INO2
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C1NC2=C(C=C(I)C=C2)/C1=C/C3=CC(Br)=C(O)C(Br)=C3
  • Chemical Name
    2H-Indol-2-one, 3-[(3,5-dibromo-4-hydroxyphenyl)methylene]-1,3-dihydro-5-iodo-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lackey K, et al. Bioorg Med Chem Lett. 2000 Feb 7;10(3):223-6. 2. Yue X, et al. Eur J Pharmacol. 2006 Jul 1;540(1-3):57-9. 3. Jensen HA, et al. Cell Signal. 2015 Aug;27(8):1666-75.
molnova catalog
related products
  • BI 882370

    BI 882370 is a highly potent, selective, orally active RAF inhibitor with IC50 of 0.4, 0.8 and 0.6 nM for BRAF V600E, BRAF WT and CRAF, respectively.

  • Lonafarnib

    Lonafarnib is an orally bioavailable FPTase inhibitor for H-ras, K-ras-4B and N-ras with IC50 of 1.9 nM, 5.2 nM and 2.8 nM, respectively. Phase 3.

  • I-37

    I-37 is a novel benzylamino substituted pyridopyrimidinone as SOS1 inhibitor.